Latest News

A primary care physician finds there's little incentive to keep up with a patient-centered medical home, except that it's the right thing to do.
While the FDA’s approval of the immunotherapy tisagenlecleucel represents a landmark in the oncology field, the treatment is far from being a cure and should be viewed in context of its $475,000 price tag, a group of oncologists wrote in a commentary published in JAMA.
The FDA has rejected an abuse-deterrent opioid citing the need for further evidence. Rexista, an Oxycodone Hydrochloride Extended-Release tablet (Oxycodone ER), was developed by Intellipharmaceutics International Inc as an abuse- and alcohol-deterrent controlled-release oral formulation of oxycodone hydrochloride for pain relief.
Researchers at the London School of Economics and Political Science have developed a multiple criteria decision analysis model, The Advance Value Framework, that payers can utilize for evaluating new medicines that come to the market.
A new study finds that participating in the Supplemental Nutrition Assistance Program (SNAP) is associated with significantly lower healthcare expenditures, pointing to the role of social determinants like food insecurity as contributors to health spending.
The move to give entrepreneurs access to patient-approved continuous glucose monitoring data fits with the company's prediction that insulin pumps will become a thing of the past, and most of the heavy lifting of delivery will be done by a smartphone.
The increasing trend in long-term prescription opioid use in the United States calls for further research on the potential benefits and harm, according to a study.
There is a dimensional relationship that links white matter structure to neurodevelopmental symptoms, such as those associated with autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD). However, more research on the connection is necessary.
Dr Paul Chew Discusses the Importance of Chronic Disease Prevention
With 35% of Americans having prediabetes, prevention is clearly a priority, but many strategies have not bee translated into clinical practice because there is no system for reimbursement yet, explained Paul Chew, MD, chief medical officer of Omada Health
With so many options for treatment-resistant depression, expert George Papakostas, MD, said all things being equal, the patient's preference counts.
Nat Turner on Flatiron Health's Emphasis on Community Oncologists
Flatiron Health focuses on helping community oncologists because they still care for the majority of patients with cancer and make it possible for patients to get care without traveling long distances, explained Nat Turner, co-founder and CEO of Flatiron Health.
Neighborhood disadvantage may be an important determinant of the risks of major atherosclerotic cardiovascular disease (ASCVD)–related events, according to a new study.
When immune-related adverse events arise from nivolumab, it may indicate that the therapy is having greater efficacy against non–small-cell lung cancer (NSCLC), as a new study demonstrates a link between these events and improved survival outcomes.

From the Journals

Studies presented at the American Diabetes Association Scientific Sessions showed that patients being treated with the ITCA 650 were less likely to need to take additional therapy to control their diabetes.
The growing importance of quality ratings will put pressure on hospitals to meet ADA standards for insulin therapy without added manpower.
Without digital health providers, Medicare's Diabetes Prevention Program could have a hard time reaching seniors in rural areas, where rates of the disease are approximately 17% higher, one leading provider argued recently.
UnitedHealthcare has not released numbers on how many patients are affected by its exclusivity deal with Medtronic. While the initial press stories criticizing the transaction have died down, a JDRF initiative calls on insurers to preserve patient choice.
The latest version of the free app offers patients a simple color-coding system to track their blood sugar status, as well as an easy way to share data with their physicians and perhaps their health plan.
An experienced market watcher who has diabetes predicts the key to success will come down to one factor: ease of use.
A multi-layered partnership with the American Association of Diabetes Educators is just one of the strategic steps in the past year for WellDoc, which offers a suite of digital diabetes products, including one with an insulin bolus calculator.
The chief medical officer of Omada Health discusses a transition from one of the world's largest pharmaceutical companies to a digital health provider, and from treating chronic disease to preventing it.
The authors examined the effect of narrow network plan selection on beneficiaries’ outpatient visits and outpatient out-of-pocket expenditures in the 2014 nongroup health insurance market.
Compendia
Adult ADHD Compendium
COPD Compendium
Dermatology Compendium
Diabetes Compendium
GI Compendium
Hematology Compendium
Immuno-oncology Compendium
Lipids Compendium
MACRA Compendium
Oncology Compendium
Pain Compendium
Reimbursement Compendium
Rheumatoid Arthritis Compendium
Know Your News
HF Compendium
Managed Care PODCAST
Formulary
Upcoming Partner Events
October 16-17, 2017
Washington, D.C.
October 24-25, 2017
San Francisco, CA

Most Popular

AJMC Strategic Alliance

$vacMongoViewPlus$